NATCO Pharma informs about analyst meet

24 Feb 2025 Evaluate

NATCO Pharma has informed that it enclosed the disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the information that the officials of the Company will be participating in meeting with investor ‘BoB Capital Markets’ (In-person) on 28th February 2025 at 3:30 pm at Hyderabad. No Unpublished price Sensitive Information (UPSI) is intended to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

860.00 -31.90 (-3.58%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×